Cervical Cancer section

Cervical Cancer News & Features

Novel Pap test may be more accurate in detecting cervical cancer

A clinical trial is underway that may provide women with a more accurate way to detect cervical cancer.

FDA approves avastin for late-stage cervical cancer

The FDA has approved a new use against late-stage cervical cancer.

HPV vaccine shows sustained efficacy, immunogenicity, and safety in long-term study

A long-term follow-up study shows the sustained efficacy, immunogenicity, and safety of GlaxoSmithKline's human papillomavirus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than 9 years, and vaccine efficacy (VE) against incident infection was 100%.

Negative HPV more predictive for low cervical cancer risk than negative Pap

An HPV test alone may provide better reassurance against cervical cancer than the Pap test alone and similar reassurance to cotesting, according to a new study.

Novel approach reduces risk of cervical cancer

Researchers describe a novel approach to preventing cervical cancer. The study findings showed a reduction in cervical cancer risk after removal of a discrete population of cervical cells called squamocolumnar junction cells.

Cervical Cancer Videos

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs